VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $116,178,000 | +34.8% | 4,999,064 | -7.7% | 4.34% | +20.7% |
| Q1 2018 | $86,192,000 | -38.5% | 5,414,064 | -20.1% | 3.59% | -39.8% |
| Q4 2017 | $140,228,000 | +13.6% | 6,778,159 | -21.3% | 5.97% | +12.4% |
| Q3 2017 | $123,423,000 | -18.4% | 8,612,913 | -1.5% | 5.31% | -13.5% |
| Q2 2017 | $151,220,000 | +90.3% | 8,741,048 | +21.3% | 6.13% | +75.4% |
| Q1 2017 | $79,479,000 | +12.7% | 7,205,675 | +48.4% | 3.50% | +13.1% |
| Q4 2016 | $70,502,000 | +25.3% | 4,855,500 | +111.9% | 3.09% | +34.2% |
| Q3 2016 | $56,254,000 | +39.2% | 2,291,400 | +14.2% | 2.30% | +27.5% |
| Q2 2016 | $40,407,000 | -2.8% | 2,006,300 | +26.9% | 1.81% | +12.9% |
| Q1 2016 | $41,579,000 | – | 1,580,950 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |